SCHEMBL20158971

SCHEMBL20158971

CCC(C)N1CC(=O)NC(=O)C1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 3/20 0.66
TOP2B Q02880 3/20 0.66
PTGS1 P23219 2/20 0.66
LMNA P02545 2/20 0.66
ALDH1A1 P00352 2/20 0.61
MAPT P10636 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
CRBN Q96SW2 3/20 0.38
KDM4E B2RXH2 3/20 0.35
CYP2C19 P33261 1/20 0.35
GRIA1 P42261 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35
PKM P14618 2/20 0.33
SIRT5 Q9NXA8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14006912 0.81 TOP2A (0.65) TOP2ATOP2BPTGS1LMNAALDH1A1
SCHEMBL3683167 0.80 TOP2A (0.58) TOP2ATOP2BPTGS1LMNAALDH1A1
SCHEMBL11929672 0.80 TOP2A (0.71) TOP2ATOP2BPTGS1LMNAALDH1A1
Dexrazoxane SCHEMBL1586271 0.79 TOP2A (1.00) TOP2ATOP2BPTGS1LMNAALDH1A1
Razoxane SCHEMBL9089 0.79 TOP2A (1.00) TOP2ATOP2BPTGS1LMNAALDH1A1
Razoxane SCHEMBL3339694 0.79 TOP2A (1.00) TOP2ATOP2BPTGS1LMNAALDH1A1
Dexrazoxane SCHEMBL18400 0.79 TOP2A (1.00) TOP2ATOP2BPTGS1LMNAALDH1A1
SCHEMBL727291 0.78 TOP2A (0.67) TOP2ATOP2BPTGS1LMNAALDH1A1
Razoxane SCHEMBL27748349 0.78 TOP2A (0.96) TOP2ATOP2BPTGS1LMNAALDH1A1
Dexrazoxane SCHEMBL18188 0.78 TOP2A (0.96) TOP2ATOP2BPTGS1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134690-A1 INDAZOLES AND USE THEREOF PURDUE PHARMA LP (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134690-A1 INDAZOLES AND USE THEREOF TRPV3, TRPA1, TRPV1 TOP2A 4448/4885TOP2B 4213/4885PTGS1 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.